Sunshine Biopharma, Inc. (SBFM)
1.12
-0.05
(-4.27%)
USD |
NASDAQ |
Sep 03, 16:00
1.12
0.00 (0.00%)
After-Hours: 16:10
Sunshine Biopharma Profit Margin (Quarterly) : -16.88% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.88% |
| March 31, 2026 | -15.38% |
| December 31, 2025 | -24.96% |
| September 30, 2025 | -9.38% |
| June 30, 2025 | -18.82% |
| March 31, 2025 | -13.25% |
| December 31, 2024 | -22.49% |
| September 30, 2024 | -14.20% |
| June 30, 2024 | -5.31% |
| March 31, 2024 | -17.02% |
| December 31, 2023 | -16.28% |
| September 30, 2023 | -10.94% |
| June 30, 2023 | -16.22% |
| March 31, 2023 | -34.78% |
| December 31, 2022 | -596.8% |
| September 30, 2022 | -1.10K% |
| June 30, 2022 | -358.5% |
| March 31, 2022 | -1.01K% |
| December 31, 2021 | |
| September 30, 2021 | -8.01K% |
| June 30, 2021 | -5.44K% |
| March 31, 2021 | -15.42K% |
| December 31, 2020 | -3.87K% |
| Date | Value |
|---|---|
| September 30, 2020 | -4.06K% |
| June 30, 2020 | -6.01K% |
| March 31, 2020 | -849.5% |
| December 31, 2019 | -3.74K% |
| September 30, 2019 | -4.80K% |
| June 30, 2019 | -4.36K% |
| March 31, 2019 | -100.2K% |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | -291.2% |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | -30.44K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
| Vericel Corp. | 2.85% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -23.91% |
| Return on Assets | -18.80% |
| Return on Invested Capital | -23.15% |
| Gross Profit Margin (Quarterly) | 25.35% |
| Operating Margin (Quarterly) | -17.41% |
| Return on Net Operating Assets | -27.73% |